Work

Analysis of interleukin-13 receptor alpha2 expression as a prognostic biomarker in surgically resected pancreatic cancer patients

Year: 2015

Type: article

Abstract: Meeting abstracts IL-13Rα2 is recognized as one of the candidate genes significantly associated with pancreatic cancer risk. Previously, we have demonstrated that IL-13Rα2 is over-expressed in ~70% of human pancreatic cancer samples. We have also shown that IL-13 can mediate invasion and

Source: Journal for ImmunoTherapy of Cancer

DOI: 10.1186/2051-1426-3-s2-p88

Authors: Toshio Fujisawa, Takeshi Shimamura, Bharat H Joshi, Raj K Puri

Institutions: NTT Medical Center, Yokohama City University, Center for Biologics Evaluation and Research, United States Food and Drug Administration

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,490